PM(2.5) and its chemical components interact with hypoxia to increase the risk of hospitalization for peripheral arterial disease

PM2.5及其化学成分与缺氧相互作用,增加外周动脉疾病住院的风险。

阅读:4

Abstract

This study investigated the combined effects of fine particulate matter (PM(2.5)) exposure and ambient oxygen (O(2)) availability on peripheral artery disease (PAD) hospitalizations in Gansu Province, China, from 2018 to 2022 (N = 38,514). A time-series case-crossover design with conditional logistic regression assessed short-term exposure to daily PM(2.5) and its major chemical components (black carbon [BC], organic carbon [OC], sulfate [SO(4) (2-)], nitrate [NO(3) (-)], ammonium [NH(4) (+)], and chloride [Cl(-)]). Atmospheric O(2) levels were estimated based on altitude, temperature, and humidity. Short-term exposure to PM(2.5) was associated with an increased risk of PAD hospitalization, notably at lag 1 (odds ratio [OR] = 1.003; 95% confidence interval [CI]: 1.002-1.004). Carbonaceous pollutants exhibited delayed effects, with peak associations at lag 6 for BC (OR = 1.069; 95% CI: 1.035-1.105) and OC (OR = 1.028; 95% CI: 1.011-1.050), per 1 μg/m(3) increase. Secondary inorganic aerosols showed acute effects at lag 1: Cl(-) (OR = 1.107; 95% CI: 1.063-1.150), NH(4) (+) (OR = 1.040; 95% CI: 1.022-1.060), SO(4) (2-) (OR = 1.025; 95% CI: 1.015-1.036), and NO(3) (-) (OR = 1.030; 95% CI: 1.018-1.042), per 1 μg/m(3) increase. Nonlinear exposure-response curves revealed a stronger PAD risk under lower O(2) conditions (<18%). The PM(2.5)-related risk was amplified in high-altitude residents (>1500 m), older adults (>60 years), females, emergency admissions, and during the cold season. These findings suggest that ambient PM(2.5) and lower O(2) levels interact synergistically to elevate PAD hospitalization risk, emphasizing the urgent need for region-specific air quality controls and targeted health protection strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。